Rich Quelch, global head of marketing, Origin looks at the barriers to adoption of sustainable packaging alternatives in pharma and how the industry is working to overcome them.
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks.
Peter Jensen, CEO and Chairman, Normax delves into why it’s time for mRNA vaccine equality to be established across the globe, how mRNA vaccines can help drive down the cost of vaccines, and support the long-term battle against future pandemics.
Despite the carbon footprint from packaging pills to active pharmaceutical ingredient (API) development, Aleiya Lonsdale, head of Event, Lab Innovations, explains how pharma companies in the UK can do their part to help achieve net zero by 2040.
Pippa White, senior global account director for Life Sciences at SAS, explores the reservations many in the life sciences industry have and highlights why now is the time to embrace analytics in the cloud.
Following the success of its laboratory for process development in India, ACG, is now also committed to launching a sister process lab in Mulheium, Germany in 2023.
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics.
Portescap’s Jigar Fulia and Kanti Vala consider the selection criteria for biologics system motion solutions in delivery devices, and how this can help meet patient needs.
Here Ian Loudon, international sales and marketing manager at remote monitoring instrumentation manufacturer Omniflex, discusses how temperature monitoring systems can be cost effective, reliable and compliant with regulatory standards.
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process.
Jason Smith, CTO, AI & Analytics, Within3, describes the possibilities made by AI in supporting the life sciences sector, and how it can allow pharma experts to produce real time results and yield better insights.
Ben Appleton and Mohammed Khimji from patent and trade mark firm, Wilson Gunn, explore the complexities, as well as the possibilities, of obtaining patent protection in Europe for inventions relating to biomarkers.
